Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
415.00
+9.25 (2.28%)
Jul 7, 2026, 2:24 PM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $335.57 billion as of July 7, 2026. Its market cap has increased by 31.79% in one year.
Market Cap
335.57B
Enterprise Value
362.59B
Revenue
79.90B
Ranking
n/a
PE Ratio
20.66
Stock Price
$415.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 335.57B, an increase of 3,731.29%. That is a compound annual growth rate of 11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 335.57B | 1.22% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 555.31M |
| Silence Therapeutics | 499.74M |
| Elite Pharmaceuticals | 387.75M |
| Glorywin Entertainment Group | 359.76M |
| American Oncology Network | 337.32M |
| CytoDyn | 323.28M |
| Northwest Biotherapeutics | 311.46M |